Sylvie Delaflotte

643 total citations
29 papers, 549 citations indexed

About

Sylvie Delaflotte is a scholar working on Physiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sylvie Delaflotte has authored 29 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 9 papers in Molecular Biology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sylvie Delaflotte's work include Nitric Oxide and Endothelin Effects (18 papers), Receptor Mechanisms and Signaling (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Sylvie Delaflotte is often cited by papers focused on Nitric Oxide and Endothelin Effects (18 papers), Receptor Mechanisms and Signaling (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Sylvie Delaflotte collaborates with scholars based in France. Sylvie Delaflotte's co-authors include P. Braquet, Michel Auguet, F Clostre, Teresa Auguet, P Chabrier, E. Pirotzky, Marie-Odile Lonchampt, P. Braquet, Pierre‐Etienne Chabrier and B. Spinnewyn and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Life Sciences.

In The Last Decade

Sylvie Delaflotte

28 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Delaflotte France 14 316 188 164 81 68 29 549
Isabelle Viossat France 16 252 0.8× 197 1.0× 217 1.3× 131 1.6× 27 0.4× 35 805
Manuel Ochoa United States 13 238 0.8× 161 0.9× 292 1.8× 22 0.3× 24 0.4× 22 606
Fred D. Romano United States 15 133 0.4× 231 1.2× 225 1.4× 64 0.8× 15 0.2× 25 557
Packiasamy A.R. Juliet Japan 11 142 0.4× 127 0.7× 47 0.3× 53 0.7× 19 0.3× 13 431
Regina Scivoletto Brazil 17 502 1.6× 136 0.7× 325 2.0× 74 0.9× 21 0.3× 40 839
Mark T. Ziolo United States 21 396 1.3× 588 3.1× 660 4.0× 92 1.1× 36 0.5× 31 1.0k
Charlene M. Hohl United States 15 116 0.4× 436 2.3× 302 1.8× 170 2.1× 19 0.3× 22 831
K Kosuga Japan 4 323 1.0× 91 0.5× 89 0.5× 71 0.9× 6 0.1× 15 404
W. J. Janssens Belgium 15 224 0.7× 162 0.9× 190 1.2× 120 1.5× 11 0.2× 31 562
Ken Terata Japan 9 252 0.8× 198 1.1× 224 1.4× 108 1.3× 6 0.1× 17 607

Countries citing papers authored by Sylvie Delaflotte

Since Specialization
Citations

This map shows the geographic impact of Sylvie Delaflotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Delaflotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Delaflotte more than expected).

Fields of papers citing papers by Sylvie Delaflotte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Delaflotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Delaflotte. The network helps show where Sylvie Delaflotte may publish in the future.

Co-authorship network of co-authors of Sylvie Delaflotte

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Delaflotte. A scholar is included among the top collaborators of Sylvie Delaflotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Delaflotte. Sylvie Delaflotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carré, Denis, B. Spinnewyn, Sylvie Delaflotte, et al.. (2011). Long-term treatment with standardized Ginkgo biloba Extract (EGb 761) attenuates cognitive deficits and hippocampal neuron loss in a gerbil model of vascular dementia. Fitoterapia. 82(7). 1075–1080. 31 indexed citations
2.
Spinnewyn, B., et al.. (2004). Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline. European Journal of Pharmacology. 505(1-3). 111–119. 25 indexed citations
3.
Delaflotte, Sylvie, Teresa Auguet, & P Chabrier. (1996). Pharmacological evidence that different a1 adrenoceptor subtypes mediate contraction in rabbit prostate and hypogastric artery. Acta Physiologica Scandinavica. 158(3). 241–251. 13 indexed citations
4.
Auguet, Teresa, et al.. (1996). Effects of angiotensin I and angiotensin II in blood vessels: greater influence of converting enzyme activity in the rabbit basilar artery. Naunyn-Schmiedeberg s Archives of Pharmacology. 354(4). 466–473. 8 indexed citations
5.
Auguet, Michel, et al.. (1995). Different α1-adrenoceptor subtypes mediate contraction in rabbit aorta and urethra. European Journal of Pharmacology. 287(2). 153–161. 23 indexed citations
6.
Auguet, Michel, Sylvie Delaflotte, Pierre‐Etienne Chabrier, & P. Braquet. (1993). Characterization of endothelin receptors mediating contraction and relaxation in rabbit saphenous artery and vein. Canadian Journal of Physiology and Pharmacology. 71(10-11). 818–823. 9 indexed citations
7.
Auguet, Michel, et al.. (1992). Induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in vascular smooth muscle cells. FEBS Letters. 297(1-2). 183–185. 50 indexed citations
8.
Lonchampt, Marie-Odile, et al.. (1992). Lipoteichoic Acid: A New Inducer of Nitric Oxide Synthase. Journal of Cardiovascular Pharmacology. 20. S145–S147. 32 indexed citations
9.
Auguet, Michel, et al.. (1992). The vasoconstrictor action of big endothelin-1 is phosphoramidon-sensitive in rabbit saphenous artery, but not in saphenous vein. European Journal of Pharmacology. 224(1). 101–102. 12 indexed citations
10.
Delaflotte, Sylvie, et al.. (1991). Endothelium independent protective effect of NG-monomethyl-L-arginine on endotoxin-induced alterations of vascular reactivity. Life Sciences. 48(2). 189–193. 15 indexed citations
11.
Delaflotte, Sylvie, et al.. (1990). Endothelin-1, but not sarafotoxin s6b, induces cross-desensitization of rat aorta contraction. European Journal of Pharmacology. 187(2). 293–294. 4 indexed citations
12.
Delaflotte, Sylvie, et al.. (1989). Increased influence of endothelium in obese Zucker rat aorta. Journal of Pharmacy and Pharmacology. 41(12). 861–864. 27 indexed citations
13.
Chabrier, P, Michel Auguet, Pierre Roubert, et al.. (1989). Vascular Mechanism of Action of Endothelin-1. Journal of Cardiovascular Pharmacology. 13. S32–35. 47 indexed citations
14.
Auguet, Teresa, Sylvie Delaflotte, E. Pirotzky, F Clostre, & P. Braquet. (1989). ROLE OF ENDOTHELIUM ON PHENYLEPHRINE‐TRIGGERED CONTRACTILE EVENTS IN AORTA OF SPONTANEOUSLY HYPERTENSIVE RATS. Fundamental and Clinical Pharmacology. 3(6). 655–664. 8 indexed citations
15.
Delaflotte, Sylvie, Teresa Auguet, E. Pirotzky, F Clostre, & P. Braquet. (1989). Effects of atrial natriuretic factor (ANF) on phenylephrine‐triggered intra‐ and extracellular calcium dependent contraction in rat aorta. Journal of Autonomic Pharmacology. 9(3). 211–218. 6 indexed citations
16.
Auguet, Michel, Sylvie Delaflotte, P Chabrier, & P. Braquet. (1989). Comparative effects of endothelin and phorbol 12–13 dibutyrate in rat aorta. Life Sciences. 45(21). 2051–2059. 19 indexed citations
17.
Delaflotte, Sylvie, et al.. (1988). Endothelin and Ca++ agonist bay K 8644: Different vasoconstrictive properties. Biochemical and Biophysical Research Communications. 156(1). 186–192. 117 indexed citations
18.
Auguet, Teresa, et al.. (1988). In vivo and in vitro effects of cicletanine in spontaneously hypertensive rats.. PubMed. 14(2-3). 89–95. 12 indexed citations
19.
Auguet, Teresa, et al.. (1988). Antihypertensive profile of cicletanine, a furopyridine derivative: Comparison with captopril, indapamide and prazosin. Pharmacological Research Communications. 20. 121–133. 8 indexed citations
20.
Auguet, Teresa, et al.. (1986). Bases pharmacologiques de l'impact vasculaire de l'extrait de Ginkgo biloba.. La Presse Médicale. 15(31). 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Viossat Breakdown of academic impact, for papers by Manuel Ochoa Breakdown of academic impact, for papers by Fred D. Romano Breakdown of academic impact, for papers by Packiasamy A.R. Juliet Breakdown of academic impact, for papers by Regina Scivoletto Breakdown of academic impact, for papers by Mark T. Ziolo Breakdown of academic impact, for papers by Charlene M. Hohl Breakdown of academic impact, for papers by K Kosuga Breakdown of academic impact, for papers by W. J. Janssens Breakdown of academic impact, for papers by Ken Terata
Rankless by CCL
2026